SOMNF (SomnoMed) NonCurrent Deferred Liabilities : $0.00 Mil (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is SomnoMed NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

SomnoMed's non-current deferred liabilities for the quarter that ended in Jun. 2024 was $0.00 Mil.

SomnoMed NonCurrent Deferred Liabilities Historical Data

The historical data trend for SomnoMed's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed NonCurrent Deferred Liabilities Chart

SomnoMed Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

NonCurrent Deferred Liabilities

Get a 7-Day Free Trial

SomnoMed Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
NonCurrent Deferred Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

SomnoMed NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of SomnoMed's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

SomnoMed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (OTCPK:SOMNF) » Definitions » NonCurrent Deferred Liabilities

Comparable Companies

Traded in Other Exchanges

RJV:Germany SOM:Australia

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.